Effects of lentivirus mediated STAT3 silencing on human chronic myeloid leukemia cells and leukemia mice

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 11, 2014, Pages 4031-4037

  Jia, Xinyan ^a   Yang, Wenzhong ^a   Han, Jia ^b   Xiong, Hong ^b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Animal model; Chronic myeloid leukemia; Lentivirus; STAT3 siRNA

Indexed keywords

CYCLIN D1; MESSENGER RNA; MYC PROTEIN; PROTEIN BCL XL; SMALL INTERFERING RNA; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; APPETITE; ARTICLE; BODY WEIGHT; CANCER CELL; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; GREY HAIR; HUMAN; HUMAN CELL; LENTIVIRINAE; LEUKEMIA; LEUKOCYTE COUNT; MALE; MOUSE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SKIN APPENDAGE; SPLEEN INDEX; SPLEEN WEIGHT; SPLENOMEGALY; WEIGHT REDUCTION; WESTERN BLOTTING;

ANIMALIA; LENTIVIRUS; MUS;

EID: 84918564459     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bartram CR, de Klein A, Hagemeijer A, van Agthoven T, Geurts van Kessel A, Bootsma D, Grosveld G, Ferguson-Smith MA, Davies T, Stone M, et al. Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature 1983; 306: 277-280.
2. Meshkini A and Yazdanparast R. Involvement of ERK/MAPK pathway in megakaryocytic differentiation of K562 cells induced by 3-hydrogenkwadaphnin. Toxicol In Vitro 2008; 22: 1503-1510.
3. Stella S, Tirro E, Conte E, Stagno F, Di Raimondo F, Manzella L and Vigneri P. Suppression of survivin induced by a BCR-ABL/JAK2/STAT3 pathway sensitizes imatinib-resistant CML cells to different cytotoxic drugs. Mol Cancer Ther 2013; 12: 1085-1098.
4. Nakamura S, Yokota D, Tan L, Nagata Y, Takemura T, Hirano I, Shigeno K, Shibata K, Fujisawa S and Ohnishi K. Down-regulation of Thanatos-associated protein 11 by BCR-ABL pro-motes CML cell proliferation through c-Myc expression. Int J Cancer 2012; 130: 1046-1059.
5. Pellicano F, Scott MT, Helgason GV, Hopcroft LE, Allan EK, Aspinall-O’Dea M, Copland M, Pierce A, Huntly BJ, Whetton AD and Holyoake TL. The Antiproliferative Activity of Kinase Inhibitors in Chronic Myeloid Leukemia Cells Is Mediated by FOXO Transcription Factors. Stem Cells 2014; 32: 2324-2337.
6. Harb JG, Neviani P, Chyla BJ, Ellis JJ, Ferenchak GJ, Oaks JJ, Walker CJ, Hokland P, Roy DC, Caligiuri MA, Marcucci G, Huettner CS and Perrotti D. Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target. Leukemia 2013; 27: 1996-2005.
7. Zhang G and Fu Y. Antiproliferative effect of indomethacin on CML cells is related to the suppression of STATs/Bcl-XL signal pathway. Ann Hematol 2006; 85: 443-449.
8. Cha Y, Moon BH, Lee MO, Ahn HJ, Lee HJ, Lee KA, Fornace AJ Jr, Kim KS, Cha HJ and Park KS. Zap70 functions to maintain stemness of mouse embryonic stem cells by negatively regulating Jak1/Stat3/c-Myc signaling. Stem Ce-lls 2010; 28: 1476-1486.
9. Bhardwaj A, Sethi G, Vadhan-Raj S, Bueso-Ramos C, Takada Y, Gaur U, Nair AS, Shishodia S and Aggarwal BB. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 2007; 109: 2293-2302.
10. Ma LD, Zhou M, Wen SH, Ni C, Jiang LJ, Fan J and Xia L. Effects of STAT3 silencing on fate of chronic myelogenous leukemia K562 cells. Leuk Lymphoma 2010; 51: 1326-1336.
11. Kim D, Lee IH, Kim S, Choi M, Kim H, Ahn S, Saw PE, Jeon H, Lee Y and Jon S. A specific STAT3-binding peptide exerts antiproliferative effects and antitumor activity by inhibiting STAT3 phosphorylation and signaling. Cancer Res 2014; 74: 2144-2151.
12. Bewry NN, Nair RR, Emmons MF, Boulware D, Pinilla-Ibarz J and Hazlehurst LA. Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance. Mol Cancer Ther 2008; 7: 3169-3175.
13. Chang G, Zhang H, Wang J, Zhang Y, Xu H, Wang C, Zhang H, Ma L, Li Q and Pang T. CD44 targets Wnt/beta-catenin pathway to mediate the proliferation of K562 cells. Cancer Cell Int 2013; 13: 117.